HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan

Nav: ₹ 17.152 ↓ -2.27%
[as on 26 September, 2025]

Nav chart with SMA (Simple moving average) overlay

SMA (Simple Moving Average)

  • 100 SMA
  • 200 SMA
  • 300 SMA
  • 400 SMA
  • 500 SMA

Returns

NameYTD1D1W1M3M1Y3Y5Y7Y10Y
HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan -1.15% -2.27% -5.11% -2.84% 1.19% 5.71%----

Portfolio

Asset allocation

EquityDebtRealestateCash & Equivalents
98.89% 1.11% (Arbitrage: 0.00%) 0.00% 0.00%

Equity

NameSectorWeight %
Sun Pharmaceutical Industries Ltd.Pharmaceuticals & Biotechnology10.39%
Divis Laboratories Ltd.Pharmaceuticals & Biotechnology8.30%
Glenmark Pharmaceuticals Ltd.Pharmaceuticals & Biotechnology6.78%
Lupin Ltd.Pharmaceuticals & Biotechnology6.73%
Cipla Ltd.Pharmaceuticals & Biotechnology6.56%
Ipca Laboratories Ltd.Pharmaceuticals & Biotechnology4.62%
Alkem Laboratories Ltd.Pharmaceuticals & Biotechnology3.94%
Torrent Pharmaceuticals Ltd.Pharmaceuticals & Biotechnology3.74%
Krishna Institute Of Medical Sciences LimitedHealthcare Services3.73%
Laurus Labs Ltd.Pharmaceuticals & Biotechnology3.62%
Eris Lifesciences LtdPharmaceuticals & Biotechnology3.60%
Anthem Biosciences LimitedPharmaceuticals & Biotechnology3.47%
Aster DM Healthcare LimitedHealthcare Services3.38%
Max Healthcare Institute LimitedHealthcare Services3.26%
Metropolis Healthcare Ltd.Healthcare Services2.82%
Vijaya Diagnostic Centre LimitedHealthcare Services2.45%
Acutaas Chemicals LimitedPharmaceuticals & Biotechnology2.44%
Gland Pharma Ltd.Pharmaceuticals & Biotechnology2.28%
Dr. Lal Path Labs LtdHealthcare Services2.04%
Cohance Lifesciences LimitedPharmaceuticals & Biotechnology1.98%
Wockhardt Ltd.Pharmaceuticals & Biotechnology1.93%
Fortis Healthcare LimitedHealthcare Services1.87%
Jubilant Pharmova LimitedPharmaceuticals & Biotechnology1.70%
Piramal Pharma LimitedPharmaceuticals & Biotechnology1.69%
Sai Life Sciences LimitedPharmaceuticals & Biotechnology1.59%
Pfizer Ltd.Pharmaceuticals & Biotechnology1.31%
BAJAJ HEALTHCARE LIMITEDPharmaceuticals & Biotechnology1.16%
Laxmi Dental LimitedHealthcare Equipment & Supplies1.15%
Medi Assist Healthcare Services LimitedInsurance0.36%

Debt

NameRatingWeight %
TREPS - Tri-party Repo1.03%
Net Current Assets0.08%
Portfolio data is as on date 31 August, 2025

FAQ (Frequently asked questions)

  • What is latest/current NAV/price of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan?
    The latest NAV of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan is 17.152 as on 26 September, 2025.
  • What are YTD (year to date) returns of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan?
    The YTD (year to date) returns of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan are -1.15% as on 26 September, 2025.
  • What are 1 year returns of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan?
    The 1 year returns of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan are 5.71% as on 26 September, 2025.